Christopher D. Thanos

Nessuna posizione attualmente

Health Technology

Profilo

Christopher D.
Thanos was the founder of Actym Therapeutics, Inc. where he held the title of President & Chief Executive Officer from 2017 to 2024.
Dr. Thanos is also the founder of Catalyst Bioscience, Inc.

Precedenti posizioni note di Christopher D. Thanos

Società	Posizione	Fine
Actym Therapeutics, Inc. Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actym Therapeutics, Inc. engages in development of novel immuno-oncology therapies. The company was founded by Christopher D. Thanos and Laura Hix Glickman and is headquartered in Berkeley, CA.	Amministratore Delegato	24/04/2024
Catalyst Bioscience, Inc. /Old/ Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA.	Fondatore	-

Vedi nel dettaglio l'esperienza di Christopher D. Thanos

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Christopher D. Thanos

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Actym Therapeutics, Inc. Actym Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Actym Therapeutics, Inc. engages in development of novel immuno-oncology therapies. The company was founded by Christopher D. Thanos and Laura Hix Glickman and is headquartered in Berkeley, CA.	Health Technology
Catalyst Bioscience, Inc. /Old/ Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Catalyst Bioscience, Inc. develops and markets catalytic biopharmaceutical products. Its technology consists of methods to identify proteases with tailor-made specificity or improved pharmacological properties. The company was founded by Charles Craik, Sandra Waugh Ruggles and Christopher Thanos in 2003 and is headquartered in South San Francisco, CA.	Health Technology